RESTASIS vs REVUMENIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RESTASIS vs REVUMENIB: Safety Overview
| Metric | RESTASIS | REVUMENIB |
|---|---|---|
| Total FAERS Reports | 1,158 | 371 |
| Deaths Reported | 0 | 49 |
| Death Rate | N/A | 13.2% |
| Hospitalizations | 5 | 93 |
| Average Patient Age | 66.9 yrs | 46.4 yrs |
| % Female Patients | N/A | 47.6% |
| FDA Approval Date | N/A | Nov 15, 2024 |
| Manufacturer | N/A | Syndax Pharmaceuticals, Inc. |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |